EPIGEX proposes innovating tools for the research and development of epigenetic diseases encompassing cancer, inflammation, and auto-immune diseases.
The company portfolio includes molecular biology reagents for the screening of therapeutic compounds, a technology for the cartography of protein interaction impaired in epigenetic diseases and a set of new tumor biomarkers. Key words :
Creation of the company : 2011
Company details :